Mémoire numérisé par la Division de la gestion de documents et des archives de l'Université de Montréal

Critical illness associated muscle weakness and muscle dysfunction in intensive care unit (ICU) patients lead to severe morbidity and mortality as well as significant adverse effect on quality of life. Immobilization, mechanical ventilation, neuromuscular blocking agents, corticosteroids, and sepsis have been implicated as important risk factors, but the underlying molecular and cellular mechanisms remain unclear.  A unique porcine ICU model was employed to investigate the effect of these risk factors on the expression profiles, gene expression and contractile properties of limb and diaphragm muscle, in the early phase of ICU stay. This project has focused on unraveling the underlying molecular and cellular pathways or networks in response to ICU and critical illness interventions. Upregulation of heat shock proteins indicated to play a protective role despite number of differentially transcribed gene groups that would otherwise have a negative effect on muscle fiber structure and function in response to immobilization and mechanical ventilation.  Mechanical ventilation appears to play a critical role in development of diaphragmatic dysfunction. Impaired autophagy, chaperone expression and protein synthesis are indicated to play a pivotal role in exacerbating muscle weakness in response to the combined effect of risk factors in ICU. These results may be of therapeutic importance in alleviating critical illness associated muscle weakness.

Studies in Europe, Japan, and North America have reported that wild fish exposed to treated sewage effluents can exhibit significant physiological and reproductive abnormalities consistent with exposure to hormonally active chemicals. The main objective of this research project was to examine the estrogenic and androgenic activity in treated sewage to determine the risk associated with treated sewage discharges in Australia and New Zealand. Several bioassays, including a sheep estrogen receptor and a rainbow trout androgen receptor binding assay, were set up and validated with model compounds. The assays were then used to measure the estrogenic and androgenic activity in sewage samples from 15 municipal sewage treatment plants (STP) utilizing a variety of treatment technologies. Raw sewage samples contained high levels of both estrogenic and androgenic activity, up to 185 ng/L estradiol equivalents (EEq) and up to 9330 ng/L testosterone equivalents (TEq), respectively. Secondary treatment processes such as activated sludge had the greatest impact on removal of biological activity from the wastewater. The estrogenic and androgenic activity in final treated effluents were <1 to 4.2 ng/L EEq and <6.5 to 736 ng/L TEq, respectively. Based on lowest observable effective concentrations reported in the literature, these levels are unlikely to induce biological effects in exposed fish in the short term. To examine potential long-term effects, resident mosquitofish chronically exposed to undiluted treated sewage were sampled. Several morphological biomarkers indicative of endocrine disruption were measured and compared with mosquitofish captured at a reference site. Mosquitofish captured in a constructed wetland for tertiary treatment of secondary treated sewage exhibited morphological differences such as elongated anal fins consistent with exposure to androgenic chemicals, although this effect was not measurable in fish collected at sites further downstream or at any of the other sites. Based on these results, it is unlikely that mosquitofish populations would be significantly affected by exposure to final treated sewage. A reverse transcription real-time polymerase chain reaction (RT-PCR) method to measure the production of a female-specific protein (vitellogenin) mRNA in adult male mosquitofish was developed, and this could be used as a rapid test to detect early changes in individuals exposed to estrogenic activity.

No description available.

Made available in DSpace on 2014-06-11T19:22:35Z (GMT). No. of bitstreams: 0 Previous issue date: 2006-01-31Bitstream added on 2014-06-13T19:26:47Z : No. of bitstreams: 1 estremote_ma_me_ilha.pdf: 1197186 bytes, checksum: a765f6c60b85ed25acef3625c598c522 (MD5) / Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) / Neste trabalho descreve-se um Software de comando para o acionamento de um braço mecânico do robô SCORBOT ER - III. O software desenvolvido tem a capacidade de controlar e monitorar o robô remotamente em tempo real através da Rede Mundial de Computadores (WWW), utilizando bibliotecas de JAVA como: métodos nativos (JNI - JAVA Native Interface), Invocação de Métodos Remotos (RMI - Remote Method Invocation), Conectividade com Banco de Dados JAVA (JDBC - JAVA Database Connecvity) e JMF (JAVA Media Frameworks) com o Protocolo de Tempo Real - RTP (Real Time Protocol). Para controle do robô, o circuito de controle originalmente desenvolvido pelo fabricante, foi reprojetado utilizando-se o ambiente Max+Plus II da Altera e a conexão entre Robô e o PC é feita através de um dispositivo lógico programável tipo FPGA, que recebe os comandos provenientes da Porta Paralela do PC, o monitoramento através de câmeras digitais do tipo WEBCAM conectadas em uma Porta do tipo USB. / This work describes the development of a Software for the control of a mechanical arm type SCORBOT ER - III. This software has the capacity to control and to monitor the robot remotely in real time through the World Wide Web (WWW), using libraries of JAVA as: native methods (JNI-JAVA Native Interface), Invocation of Remote Methods (RMI - Remote Method Invocation), Connecvity with database JAVA (JDBC - JAVA Database Connecvity) and JMF (JAVA Media Frameworks) with the Protocol of Real Time - RTP (Real Time Protocol). The robot control circuit was redesigned using the Altera Max+Plus II environment and the connection between the robot and personal computer was made by the Parallel Port and digital cameras of the type WEBCAM, connected USB port.

Made available in DSpace on 2014-12-17T15:06:39Z (GMT). No. of bitstreams: 1 RomaoISJ.pdf: 1136533 bytes, checksum: 3630b79e4523766bd684886353ecbb9e (MD5) Previous issue date: 2006-10-31 / The present research intends to propose a reading in a new dimension of the fantastic (weird) literature and, especially, of its Brazilian more representative author, Murilo Rubi?o. At the beginning with concepts and associations with the erotic, starting from the myth of Eros and Psique and developing relations with Georges Bataille's theory on the theme. Afterwards, other associations are made, now with relation to the own fantastic literature. With the essence of this literature, examples of the traditional close to the contemporary. A last, association is made with the absurd literature. The contemporary man as being object and its configuration represented in the field of the dreams and its possibilities. At the end of the work, a "post scriptum" suggests a more imersive reading of tales in the entire that appeared broken into fragments along the research / A presente disserta??o tem o intuito de propor uma leitura redimensionada da literatura fant?stica e, em especial, de seu maior representante brasileiro, o autor mineiro Murilo Rubi?o. De in?cio com conceitos e associa??es quanto ao erotismo, partindo do mito de Eros e Psiqu? e desenvolvendo rela??es com a teoria de Georges Bataille sobre o tema. Em seguida outras associa??es s?o feitas, com rela??o ? pr?pria literatura fant?stica. A busca do reencontro com a ess?ncia deste g?nero apresenta-se junto a exemplos do tradicional e do contempor?neo. Uma ?ltima associa??o ? feita com o g?nero absurdo. O homem contempor?neo como ser objeto e sua configura??o representada no campo on?rico das possibilidades. Ao final do trabalho, um post scriptum sugere uma leitura mais imersiva de contos na ?ntegra que surgiram fragmentados ao longo da disserta??o

CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / O câncer de mama é a neoplasia que mais acomete mulheres no mundo. Dentre os fatores prognósticos levados em consideração estão os receptores hormonais. O receptor de estrógeno beta (ERβ) é um dos receptores hormonais que pode ser encontrado na mama, mas que até então não é utilizado como um marcador preditivo de prognóstico tumoral por conta da sua ação paradoxal. Células tumorais de mama da linhagem MCF-7 foram utilizadas neste trabalho para averiguar a função dicotômica do ERβ no processo tumoral. De tal forma que foi avaliado alguns dos processos que são observados nas etapas do desenvolvimento do câncer de mama, como proliferação, transição epitélio-mesênquima (EMT) e investigação das células -tronco cancerosas (CSCs) . Para isso, foram utilizados o agonista de ERβ, Diarilpropionitrilo (DPN), o agonista ambíguo (ERα e ERβ) estradiol (E2) e o fator de crescimento transformante beta (TGF-β), indutor de EMT. As células que receberam tratamento com DPN obtiveram maior número de CSCs comparadas às que não foram cultivadas com esse agonista, resultado encontrado pela técnica de citometria de fluxo. As células que tiveram um tratamento prévio com TGF-β demonstraram menor taxa de proliferação e aumento na expressão de p21, uma proteína com ação bloqueadora de ciclina D1, cuja expressão ficou inalterada nos tratamentos com TGF-β e agonista de ERβ. A respeito dos genes relacionados a EMT (SLUG, SNAIL,VIMENTINA, ZEB1,TWIST1,RBFOX2,CICLINAD1 e p21), ERβ inibiu a expressão dos mesmos, sugerindo que esse receptor induza o fenômeno denominado transição mesenquimal epitelial (MET). Nesse cenário, DPN causou a diminuição da expressão de SLUG, SNAIL, TWIST, contrastando com a expressão obtida no tratamento com TGF-β que, além desses genes, também demonstrou aumento na expressão de ZEB1, RBFOX2 e vimentina. O efeito do TGF-β na EMT foi revertido ao associá-lo com DPN. Os dados corroboram com a literatura acerca do possível papel pró tumoral de ERβ no aumento da proliferação celular e da geração das células-tronco cancerígenas de mama (BSCs), além de ir ao encontro do fenótipo relacionado a MET nos tratamentos com DPN sozinho ou associado ao TGF-β. Com esses resultados, torna-se claro no nosso trabalho que dependendo o que é avaliado em relação a ação do ERβ, previamente tratado ou não com TGF-β, o seu efeito dicotômico ainda é observado. / Breast cancer is the most common neoplasm of women in the world. Among the prognostic factors taken into consideration are the hormonal receptors. The estrogen receptor beta (ERβ) is one of the hormone receptors that can be found in the breast, but is not used as a predictive marker of tumor prognosis due to its paradoxical action. Tumor cells of the MCF-7 lineage were used in this work to ascertain the dichotomic function of ERβ in the tumor process. Thus, we evaluated some of the processes that are observed in the stages of breast cancer development, such as proliferation, epithelial-mesenchymal transition (EMT) and cancer stem cell research (CSCs). For this, ERβ agonist Diarilpropionitrile (DPN), ambiguous agonist (ERα and ERβ) estradiol (E2) and transforming growth factor beta (TGF-β), inducer of EMT, were used. Cells receiving TGF- β treatment obtained a higher number of CSCs compared to those that were not cultured with this agonist, a result found by the flow cytometry technique. Cells that were pretreated with TGF-β demonstrated a lower rate of proliferation and increased expression of p21, a protein with cyclin D1 blocking action, whose expression was unchanged in TGF-β and ERβ agonist treatments. Regarding the EMT-related genes (SLUG, SNAIL, VIMENTINA, ZEB1, TWIST1, RBFOX2, CYCLINAD1 and p21), ERβ inhibited their expression, suggesting that this receptor induces the phenomenon called epithelial mesenchymal transition (MET). In this scenario, DPN caused a decrease in the expression of SLUG, SNAIL, TWIST, in contrast to TGF-β expression, which, in addition to these genes, also showed increased expression of ZEB1, RBFOX2 and VIMENTIN. The effect of TGF-β on EMT was reversed by associating it with DPN. The data corroborate with the literature about the possible ERβ pro-tumor role in increasing cell proliferation and the generation of breast cancer stem cells (BSCs), in addition to the MET related phenotype in treatments with DPN alone or associated to TGF-β. With these results, it becomes clear in our work that depending on what is evaluated in relation to the action of ERβ, previously treated or not with TGF-β, its dichotomous effect is still observed. / Dissertação (Mestrado)

Abstract The opioid receptors (&#948;, &#954; and &#956;) are family A G protein-coupled receptors (GPCRs) that have an important role in the regulation of pain. Like all GPCRs they have a common structure that consists of seven transmembrane domains with an extracellular amino (N)-terminus and an intracellular carboxyl-terminus. The human &#948; opioid receptor (h(&#948;OR) has two polymorphic variants. A single-nucleotide polymorphism causes replacement of Phe with Cys at the amino acid position 27 in the receptor N-terminus. The allelic frequency of h&#948;ORCys27, the less common variant, is about 10% in Caucasians. In this study, the two h&#948;OR variants were expressed in heterologous expression systems and their biosynthesis was characterized in detail using various cell biological and biochemical techniques. In particular, the role of receptor heteromerization and opioid receptor pharmacological chaperones in processing, maturation and trafficking of the variants was assessed. The h&#948;OR variants showed significant differences in maturation and trafficking. The h&#948;ORCys27 had a significantly lower maturation efficiency compared with h&#948;ORPhe27. In addition, long-term receptor expression led to the accumulation of h&#948;ORCys27 in the endoplasmic reticulum (ER) and also impaired receptor targeting to ER-associated degradation. The h&#948;OR variants also differed at the cell surface, as the h&#948;ORCys27 variant was internalized constitutively in a faster and more extensive manner than h&#948;ORPhe27. However, the variants had similar pharmacological properties and activated G proteins in an identical manner. This study also showed that h&#948;ORCys27 acted in a dominant negative manner and redirected some h&#948;ORPhe27 precursors to degradation. This resulted in impaired plasma membrane expression of h&#948;ORPhe27 in co-transfected cells. The h&#948;OR variants were found to form heteromers early in the secretory pathway, which is the most likely reason for the dominant negative behavior of h&#948;ORCys27 on h&#948;ORPhe27. The mechanism of action of opioid receptor pharmacological chaperones, membrane-permeable opioid ligands, was investigated in detail using h&#948;ORCys27 and its mutant form h&#948;ORCys27-(Asp95Ala) as models. Opioid antagonists were found to be able to bind to and stabilize receptor precursors in the ER and enhance their dissociation from the ER molecular chaperone calnexin. This led to an increase in the number of receptors at the plasma membrane. In addition, h&#948;ORPhe27, like h&#948;ORCys27, was responsive to antagonist treatment whether the variants were expressed together or individually. / Tiivistelmä Opioidireseptorit kuuluvat G-proteiinikytkentäisiin reseptoreihin, ja niillä on tärkeä rooli kipuaistimuksen säätelyssä. Ne ovat solukalvoproteiineja, joiden aminohappoketju läpäisee kalvon seitsemän kertaa. Reseptorien aminoterminaalipää sijaitsee solun ulkopuolella ja karboksiterminaalipää solun sisällä. Ihmisen &#948;-opioidireseptori esiintyy kahtena polymorfisena muotona, Phe27:nä ja Cys27:nä, joissa aminohappo 27 on joko fenyylialaniini (Phe) tai kysteiini (Cys). Cys27 on harvinaisempi muoto, ja sen yleisyys on noin 10 % eurooppalaista alkuperää olevalla väestöllä. Tämän väitöskirjan tavoitteena oli tutkia &#948;-opioidireseptorin varianttimuotojen biosynteesiä reseptoriproteiinia tuottavissa heterologisissa solumalleissa (HEK293- ja SH-SY5Y-solut) solubiologisilla ja biokemiallisilla menetelmillä.. Väitöskirja osoittaa, että &#948;-opioidireseptorin varianttimuotojen välillä on eroa prosessoinnissa. Cys27-varianttia kuljetetaan endoplasmakalvostosta solun pinnalle vähemmän kuin Phe27-varianttia, ja pitkäaikainen reseptorituotanto johtaa vastasyntetisoituneiden reseptorien kerääntymiseen solun sisälle. Samalla reseptorien ohjaus proteasomihajotukseen heikkenee. Soluissa, jotka tuottavat molempia varianttimuotoja samanaikaisesti, Cys27-variantin havaittiin ohjaavan myös Phe27-varianttia proteasomihajotukseen vähentäen sen kuljetusta solun pinnalle. Tämä Cys27-variantin dominanttinegatiivinen ominaisuus johtuu todennäköisesti siitä, että variantit muodostavat dimeerisen rakenteen endoplasmakalvostossa. Havaittiin myös, että Cys27-varianttireseptorit ohjataan solun pinnalta lysosomihajotukseen tehokkaammin kuin vastaavat Phe27-varianttimuodot. Prosessointieroista huolimatta variantit eivät poikkea toisistaan farmakologisilta ominaisuuksiltaan, ja ne aktivoivat G proteiineja samalla tavalla. Väitöskirjassa tutkittiin myös farmakologisten kaperonien toimintamekanismeja käyttämällä mallina &#948;-opioidireseptorin Cys27-varianttia ja sen pistemutaatiota (Asp95Ala). Farmakologisten kaperonien eli reseptorispesifisten ligandien todettiin sitoutuvan reseptoreihin endoplasmakalvostossa ja stabiloivan niiden rakennetta, mikä vähentää reseptorin ja proteiinien laadunvalvontaan osallistuvan kaperonin, kalneksiinin, välistä vuorovaikutusta. Tämä johtaa reseptorien määrän kasvuun solun pinnalla.

La survie des cellules T naïves est essentielle au bon fonctionnement du système immunitaire à long terme. Les rats BBDP (Bio-breeding Diabetes prone) sont caractérisés par une haute prédisposition au développement du diabète ainsi que par une diminution significative du nombre de cellules T naïves. Ces rats comportent une mutation de type décalage de lecture dans le gène codant pour «GTPase Immunity-Associated Protein 5» (Gimap5) ce qui entraine l’apoptose des lymphocytes T. Le mécanisme par lequel la déficience de la protéine GIMAP5 conduit les cellules T à la mort est actuellement méconnu. GIMAP5 a également été associée à différentes maladies auto-immunes, ce qui suggère son influence dans l'homéostasie des lymphocytes T. Des résultats antérieurs de notre groupe de recherche ont montré que l'absence de GIMAP5 entraîne une diminution du flux de Ca2+ ainsi qu’une réduction de la capacité mitochondriale à emmagasiner du Ca2+ suite à la stimulation du TCR. Cependant, GIMAP5 n'est pas une protéine mitochondriale. Afin de mieux comprendre le rôle de GIMAP5 dans la biologie des cellules T, au cours de mes études doctorales, je me suis concentré sur la localisation cellulaire de la protéine ainsi que sur son rôle dans l'homéostasie du Ca2+. Comme modèle d’étude, j'ai établi des lignées cellulaires HEK293T stables pour l’expression de GIMAP5, ainsi que pour différents mutants et variantes de la protéine. Ceci m’a permis d’élucider l'importance du domaine transmembranaire (TM) pour la localisation et le rôle physiologique de GIMAP5 ainsi que la différence entre les deux variantes de cette protéine. Mes résultats ont permis de montrer que l'expression de Gimap5 ne semble pas être nécessaire après l’activation des lymphocytes T. En parallèle, j'ai confirmé nos observations antérieures qui démontrent l’influence de GIMAP5 dans l'homéostasie du Ca2+ et sa colocalization avec les microtubules. En outre, j'ai montré que GIMAP5 se trouve dans des structures de type vésiculaire, particulièrement dans la membrane lysosomale où son domaine TM est essentiel à son bon fonctionnement et localisation. Mes résultats suggèrent que les mitochondries exhibent un défaut dans leur capacité à emmagasiner du Ca2+ au niveau basal, ainsi que suite à l’activation du TCR. Enfin, j'ai démontré pour la première fois, que l'influence de GIMAP5 sur le stockage de Ca2+ lysosomal peut avoir un impact sur la survie des lymphocytes T. D’après ces observations, une des fonctions probables de GIMAP5 serait d’empêcher la fermeture prématurée des canaux de relâche calcique. Finalement, GIMAP5 pourrait être engagé dans des mécanismes visant à prolonger et raffiner la signalisation du Ca2+ dans les cellules T. Bref, la régulation du Ca2+ lysosomal médié par GIMAP5 est essentielle à la survie de cellules T naïves. / Abstract: Healthy and long-term survival of naïve T cells is essential for proper functioning of the immune system. In bio-breeding diabetes prone (BBDP) rats, there is a critical decrease in the number of naïve T cells. In these rats, a recessive frameshift mutation in the GTPase of Immune-Associated Protein 5 (Gimap5) gene induces lymphocytes to undergo spontaneous apoptosis. The death of T cells driven by a deficiency of the GIMAP5 is currently not fully understood. Interestingly, different autoimmune diseases have shown an association with perturbations in the Gimap5 gene, which further suggests its influence in basal lymphocyte homeostasis. Previous findings by our group have shown that the absence of GIMAP5 results in a decrease calcium flux following TCR stimulation and an impaired capacity of the mitochondria to buffer calcium entry. However, GIMAP5 is not a mitochondrial protein. During my Ph.D. studies, I focused on clarifying the cellular localization of GIMAP5 as well as its function in Ca2+ homeostasis in order to further understand its role in T cell biology. As a model, I established HEK293T cells stable for the expression of the different mutants and variants of the GIMAP5 protein. Where I uncovered the importance of the transmembrane domain (TM) for GIMAP5 localization and physiological role, as well as the differences between the two variants of GIMAP5. The results obtained show that the expression of Gimap5 is no longer needed after T cells activation. Moreover, our previous observations were confirmed and expanded upon regarding GIMAP5’s influence on Ca2+ homeostasis and colocalization with the cytoskeleton. It was also shown that GIMAP5 localizes to vesicular-like structures, particularly to the lysosomal membrane, where its TM domain is critical for proper functioning and localization. My results suggest that the mitochondria might be impaired to uptake as well as retain Ca2+ at their full capacity in the absence of GIMAP5. Finally, I observed for the first time that GIMAP5’s influence on lysosomal Ca2+ storage could impact lymphocyte survival. These results suggest that GIMAP5 may work as a backup mechanism to prevent premature closure of Ca2+ channels and Ca2+ influx or as a mechanism to prolong and refine Ca2+ signaling in T cells.

La progression tumorale repose sur l'acquisition progressive d'anomalies génétiques qui vont conduire à la prolifération dérégulée de ces cellules. Il existe cependant des systèmes de protection contre cette progression tumorale que l'on appelle systèmes de sauvegarde. Ainsi, pour se transformer, la cellule tumorale doit franchir ces barrières anti-tumorales. Les résultats de mon travail de thèse, qui avait pour objectif initial d'identifier les altérations moléculaires précoces de l'oncogenèse, m'ont permis de mettre en évidence un nouveau mécanisme de sauvegarde anti-tumoral. Pour cette étude, un modèle d'étude in vitro de l'initiation et de la progression tumorale déclenchée par l'oncogène RET développé par notre équipe a été utilisé. Grâce à l'utilisation de ce système, nous avons pu montrer que le Réticulum Endoplasmique (RE) est un senseur efficace de l'altération du métabolisme glucidique déclenchée par les signalisations oncogéniques, et que le stress qu'il subit alors, conduit à l'apoptose. Ce travail a permis de mettre mis en évidence que les cellules malignes qui franchissent cette barrière peuvent alors bénéficier d'un effet pro-tumorale du SRE. Ainsi, les résultats présentés dans ce manuscrit offrent une meilleure compréhension du rôle complexe que joue le SRE dans la cancérogénèse / Carcinogenesis involves not only inactivation of tumourigenesis barriers, but also alterations in energy metabolism to fulfil the synthetic and bioenergetic requirements for fast and uncontrolled growth. Our study supports a model in which the ER acts as a node between altered glucose metabolism and tumourigenesis barriers. This major site in the cell for protein folding and maturation, can sense glucose limitation that results from oncogenic-mediated increased glucose demand, and consequently trigger unfolded protein response-dependent apoptosis. As such, the ER functions as a surveillance mechanism that suppresses the emergence of tumour cells. Overcoming this early barrier involves a specific attenuation of the pro-apoptotic PERK-CHOP branch of the unfolded protein response, a cellular adaptation that in turn may favour malignant progression. These observations bring new insights into the complex role of the unfolded protein response during tumourigenesis